Literature DB >> 6690551

Two-dimensional contrast echocardiography. II. Transpulmonary studies.

F J Ten Cate, S Feinstein, W Zwehl, S Meerbaum, M Fishbein, P M Shah, E Corday.   

Abstract

A method using contrast two-dimensional echocardiography for left ventricular chamber and myocardial opacification from a right-sided pulmonary capillary wedge position is described. A total of 152 studies were carried out in nine mongrel dogs. Four different catheters with different catheter tip cross-sectional areas (varying from 0.75 to 2.3 mm2) were used. In addition, catheter position (six different positions in the pulmonary circulation), pressure of injection and type of echo contrast agent (hand-agitated and sonicated) were studied. In all 152 studies, two independent observers agreed that echo contrast was seen in the left ventricular chamber after a pulmonary capillary wedge injection of 8 cc of echo contrast agent followed by a flush injection of 8 cc saline solution. In 71% of the studies, the two independent observers agreed about the degree of opacification on a qualitative scale of 0 to 3+. Time from injection from the catheter tip to the appearance of echo contrast in the left atrium was 6.2 +/- 4.8 seconds for sonicated Renografin-76 and 2.8 +/- 0.6 seconds for sonicated sorbitol 70% (p less than 0.05). Correlation for the disappearance rate of echo contrast as determined for the region in the mid left ventricular chamber and thermodilution cardiac output was fair (r = -0.78; n = 14). In 24 studies, it was not possible to demonstrate the appearance of echo contrast in the myocardium. Peak videointensity of 10 duplicate injections showed a mean percent error of 10.4 +/- 2.1% for sonicated Renografin-76 and 1.4 +/- 0.8% for sonicated sorbitol 70%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690551     DOI: 10.1016/s0735-1097(84)80425-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Microbubbles in ultrasound-triggered drug and gene delivery.

Authors:  Sophie Hernot; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

2.  Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.

Authors:  R Leischik; K D Beller; R Erbel
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

Review 3.  Contrast echocardiography for assessment of myocardial perfusion.

Authors:  R Leischik; J Rose; G Caspari; A Skyschally; G Heusch; R Erbel
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

Review 4.  Quantitation in echocardiography.

Authors:  D J Skorton; S M Collins
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

5.  Sonicated X-ray contrast agents for quantitative myocardial contrast echocardiography--a critical approach.

Authors:  I V Mayer; M P Lazarov; U Utzinger; A U Freiburghaus; O M Hess
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

6.  Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963).

Authors:  R Leischik; C Kuhlmann; C Bruch; A Jeremias; T Buck; R Erbel
Journal:  Int J Card Imaging       Date:  1997-10

Review 7.  Current status and prospects for microbubbles in ultrasound theranostics.

Authors:  K Heath Martin; Paul A Dayton
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-03-15

Review 8.  Intravascular targets for molecular contrast-enhanced ultrasound imaging.

Authors:  Siver A Moestue; Ingrid S Gribbestad; Rune Hansen
Journal:  Int J Mol Sci       Date:  2012-06-01       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.